Showing results (471-480 of 529) with videos related to

Sort By:
Pageof 53
Schizophrenia (Heidelberg, Germany)|July 19, 2022
Dissecting schizophrenia phenotypic variation: the contribution of genetic variation, environmental exposures, and gene-environment interactionsHanxin Zhang, Atif Khan, Steven A Kushner, et al.
Schizophrenia (Heidelberg, Germany)|July 19, 2022
Who does what to whom? graph representations of action-predication in speech relate to psychopathological dimensions of psychosisAmir H Nikzad, Yan Cong, Sarah Berretta, et al.
Schizophrenia (Heidelberg, Germany)|July 19, 2022
Impaired sense of agency and associated confidence in psychosisAmit Regev Krugwasser, Yonatan Stern, Nathan Faivre, et al.
Schizophrenia (Heidelberg, Germany)|May 20, 2023
Nicotinamide ameliorates mitochondria-related neuronal apoptosis and cognitive impairment via the NAD+/SIRT3 pathwayKeke Hao, Fashuai Chen, Linyao Zhao, et al.
Schizophrenia (Heidelberg, Germany)|March 15, 2023
Connectivity alterations of mesostriatal pathways in first episode psychosisNicholas Mark Edward Alexander Hayward, Ana María Triana, Jonatan M Panula, et al.
Schizophrenia (Heidelberg, Germany)|February 11, 2023
Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategiesChristoph U Correll, Carmela Benson, Bruno Emond, et al.
Schizophrenia (Heidelberg, Germany)|August 18, 2022
Targeted metabolomics reveals aberrant profiles of serum bile acids in patients with schizophreniaYing Qing, Pengkun Wang, Gaoping Cui, et al.
Schizophrenia (Heidelberg, Germany)|November 5, 2022
Alteration of a brain network with stable and strong functional connections in subjects with schizophreniaLiu Yuan, Xiaoqian Ma, David Li, et al.
Schizophrenia (Heidelberg, Germany)|November 8, 2022
Disrupted local functional connectivity in schizophrenia: An updated and extended meta-analysisMengjing Cai, Rui Wang, Mengge Liu, et al.
Schizophrenia (Heidelberg, Germany)|December 8, 2025
Alterations in serum IL-10 and IL-19 levels in drug-naïve first-episode adolescent-onset schizophrenia and their associations with clinical symptomsHaidong Yang, Zhihui Shi, Li Xu, et al.
Pageof 53